1-15 of 15
Jianzhen Shen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and safety of zanubrutinib combination therapy and monotherapy maintenance in patients with follicular lymphoma: A retrospective single-center analysis

Free
Jianzhen Shen, Xiaofeng Luo, Qian Huang, Yumin Fu
Journal: Blood
Blood (2025) 146 (Supplement 1): 7112.
https://doi.org/10.1182/blood-2025-7112
Published: 2025
Journal Articles

Orelabrutinib plus bendamustine-rituximab (OBR) Versus Bendamustine-rituximab (BR) in transplant-ineligible, intermediate- to high-risk Mantle Cell Lymphoma (MCL)

Free
Li Wang, Jianzhen Shen, Yaohui Huang, Jing Bao, Lin Shen, Pengpeng Xu, Shu Cheng, Hongming Zhu, Weili Zhao
Journal: Blood
Blood (2025) 146 (Supplement 1): 3599.
https://doi.org/10.1182/blood-2025-3599
Published: 2025
Journal Articles

Efficacy and safety of rocbrutinib, the fourth generation bruton's tyrosine kinase inhibitor, in patients with BTK inhibitor pre-treated relapsed or refractory Mantle Cell Lymphoma: Results from a Phase II rock-1 trial

Free
Yuqin Song, Qingqing Cai, Xiaoqiong Tang, Keshu Zhou, Lihong Liu, Zhigang Peng, Xiaojing Yan, Kaiyang Ding, Jianzhen Shen, Huijing Wu, Jie Cui, Hui Zhou, Jianqiu Wu, Hongmei Jing, Ming Jiang, Xiuhua Sun, Yu Yang, Kang Yu, Wei Yang, Zhifeng Li, Zhengming Jin, Shuhua Yi, Fei Li, Guowu Wu, Xiaolei Wei, Gaoxiang Wang, Yudan Wu, Ningjing Lin, Fenlai Tan, Yue Shen, Yejiang Lou, Xiang Xiao, Jun Zhu
Journal: Blood
Blood (2025) 146 (Supplement 1): 886.
https://doi.org/10.1182/blood-2025-886
Published: 2025
Journal Articles

A prospective, multicenter, real-world study of glofitamab in Chinese patients with relapsed or refractory large B-cell lymphoma

Free
Li Wang, Jiayin He, Zhihua Yao, Hongmei Jing, Songfu Jiang, Xia Zhao, Wenrong Huang, Hongbin Lu, Zhao Peiqi, Lihong Liu, Jianzhen Shen, Wei Li Zhao
Journal: Blood
Blood (2025) 146 (Supplement 1): 7252.
https://doi.org/10.1182/blood-2025-7252
Published: 2025
Journal Articles

Pola-R-CHP in previously untreated low-risk (IPI 0-1) DLBCL: A nationwide multicenter retrospective study in China

Free
Yuhong Ren, Jia Liu, Zhijuan Lin, Lihong Shou, Hui Zeng, Dong Wu, Zhiyong Zeng, Fengping Zhou, Li Bao, Hongmei Jing, Songfu Jiang, Haisheng Liu, Jianzhen Shen, Wenjuan Yu, Hui Zhou, Jingyan Xu, Yan Zhang, Ting Wang, Honghui Huang, Bing Xu, Peng Liu
Journal: Blood
Blood (2025) 146 (Supplement 1): 7229.
https://doi.org/10.1182/blood-2025-7229
Published: 2025
Journal Articles

Tucidinostat plus R-CHOP in untreated MYC/BCL2 double-expressor diffuse large B-cell lymphoma：topline efficacy and safety results from the randomized phase 3 DEB study

Free
Wei Li Zhao, Jun Zhu, Pengpeng Xu, Yuqin Song, Jianzhen Shen, Qingqing Cai, Hui Zhou, Liling Zhang, Ying Xiang, Xiuhua Sun, Wei Yang, Zhihua Yao, Hongmei Jing, Shujuan Wen, Jie Jin, Hongwei Xue, Hong Cen, Kaiyang Ding, Zhengming Jin, Lihong Liu, Xiaojing Xing, Lanfang Li, Ming Hou, Lin LIU, Mingzhi Zhang, Wenyu Li, Ou Bai, Ru Feng, Zunmin Zhu, Huijing Wu, Liping Su, Li Gao, Fei Li, Wenrong Huang, Peng Liu, Xiaojing Yan, Ying Zhao, Hang Su, Xielan Zhao, Rong FU, Hong Liu, Wenyu Shi
Journal: Blood
Blood (2025) 146 (Supplement 1): 475.
https://doi.org/10.1182/blood-2025-475
Published: 2025
Journal Articles

Practice pattern and outcomes in DLBCL by Genetic Subtypes: Preliminary results from a large-scale real-world study in China

Free
Pengpeng Xu, Hongmei Jing, Songfu Jiang, Keshu Zhou, Wenrong Huang, Xiaoxi Zhou, Jianzhen Shen, Xiuhua Sun, Xiaobo Wang, Bing Xiu, Xiaojing Yan, Ting Niu, Hongling Peng, Haisheng Liu, Sujiang Zhang, Wei Sang, Yanli Yang, Yingyu Nan, Yao Liu, Wuping Li, Lijie Xing, Chunling Wang, Jingyan Xu, Qianqian Cai, Ying Zhao, Xudong Zhang, Zhengzi Qian, Jinhai Ren, Aili He, Li Wang, Yue Wang, Muchen Zhang, Yang He, Wei Li Zhao
Journal: Blood
Blood (2025) 146 (Supplement 1): 3689.
https://doi.org/10.1182/blood-2025-3689
Published: 2025
Journal Articles

Combination of Mitoxantrone Hydrochloride Liposome with Tislelizumab in Patients with Relapsed or Refractory NK/T Cell Lymphoma: A Phase Ib/Ⅱ Study

Free
Qingqing Cai, Yi Xia, Liang Wang, Dongfeng Zeng, Hongyan Tong, Huiqiang Huang, Yuerong Shuang, Zhigang Peng, Ying Zhao, Xiaobo Wang, Xiuhua Sun, Yu Yang, Daoguang Chen, Zhenya Hong, Jinni Wang, Jun Cai, Wei Zhang, Rong Tao, Hong Cen, Jianzhen Shen, Yirong Jiang, Yan Gao, Xiaojie Fang, Man Nie, Xuanye Zhang, Bing Bai, Yuchen Zhang, Qihua Zou, Xi Li, Chunmei Yang, Xin Gao, Hao Xu
Journal: Blood
Blood (2024) 144 (Supplement 1): 4450.
https://doi.org/10.1182/blood-2024-209224
Published: 2024
Journal Articles

Analysis of High-Risk Factors and Establishment of an Early Warning Model for Thromboembolism in Lymphoma Patients

Free
Wenzheng Lin, Lili Pan, Jiangrui Guo, Tingbo Liu, Jianzhen Shen, Xiaofan Li
Journal: Blood
Blood (2024) 144 (Supplement 1): 6461.
https://doi.org/10.1182/blood-2024-203367
Published: 2024
Journal Articles

Characteristics and Prognosis of Epstein Barr Virus-Positive Diffuse Large B-Cell Lymphoma: A Retrospective, Single-Center Study

Free
Qiaochu Lin, Lianming Liao, Tingbo Liu, Jianzhen Shen, Xiaofeng Luo, Haiying Fu, Xiaofan Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 6151.
https://doi.org/10.1182/blood-2023-185281
Published: 2023
Journal Articles

This Is a Title in Title Case: A Retrospective Study for 14 R/R DLBCL Patients

Free
Jianzhen Shen, Xiaofan Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 6309.
https://doi.org/10.1182/blood-2023-188389
Published: 2023
Journal Articles

Clinical Features and Prognosis Analysis of 168 Cases of MYC/BCL2 Double Expression Diffuse Large B Lymphoma

Free
Qingfeng Chen, Tingbo Liu, Jianzhen Shen, Xiaofan Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 6153.
https://doi.org/10.1182/blood-2023-185973
Published: 2023
Journal Articles

Diagnostic and Prognostic Evaluation Value of 18 f-FDG PET-CT for Bone Marrow Infiltration in Primary Treated Follicular Lymphoma

Free
Yu Zhao, Jianzhen Shen, Tingbo Liu, Xiaofan Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 6154.
https://doi.org/10.1182/blood-2023-186231
Published: 2023
Journal Articles

A Multicenter, Open-Label, Single-Arm, Phase Ib Clinical Trial of HH2853 in the Treatment of Patients with Relapsed and/or Refractory Peripheral T-Cell Lymphoma

Free
Huangming Hong, Mingzhi Zhang, Zhigang Peng, Jianzhen Shen, Yuerong Shuang, Hui Zhou, Hongqiang Guo, He Huang, Fei Li, Zhengzi Qian, Lihong Liu, Liang Wang, Wei Yang, Liling Zhang, Pengcheng He, Shen Qian, Fugen Li, Meng Li, Tongyu Lin
Journal: Blood
Blood (2023) 142 (Supplement 1): 304.
https://doi.org/10.1182/blood-2023-180372
Published: 2023
Journal Articles

Clinical Outcomes of Different Regimens in Patients Newly Diagnosed with Acute Promyelocytic Leukemia

Free
Rui Qin, Xiaofan Li, MD PhD, Nainong LI, Meijuan Huang, Zheng Jing, Fenge Yang, Yuanzhong Chen, Jianda Hu, Prof MDPhD, Rong Zhan, Shaoyuan Wang, Zhizhe Chen, Prof.MD, Jianzhen Shen, Danhui Fu, Yanjuan Lin, Tingbo Liu
Journal: Blood
Blood (2017) 130 (Supplement 1): 2617.
https://doi.org/10.1182/blood.V130.Suppl_1.2617.2617
Published: 2017